Biotech


  • Image attribution tooltip
    Stock via Getty Images

    How Big Pharma is prepping for the late 2020s patent cliff

    Ratings agency Moody’s lays out the risk exposure for industry leaders.

    By Kim Ribbink • July 6, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Pharma companies take a fresh approach to inclusion in new DTC ads

    AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

    By July 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform

    As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.

    By Kim Ribbink • June 30, 2022
  • Image attribution tooltip
    Permission granted by University of Pennsylvania
    Q&A

    The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

    The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

    By June 29, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

    The latest personnel changes from around the industry.

    By June 29, 2022
  • Image attribution tooltip
    iStock via Getty Images

    A myriad of blows: Who's getting hit the hardest by the economy's troubles

    The downturn shows few signs of hurting large pharma, but small biotechs and generics makers could face a credit crunch.

    By Kim Ribbink • June 27, 2022
  • Image attribution tooltip
    Permission granted by SaNOtize/Gilly Regev
    Profile

    From vineyards to antivirals, Gilly Regev brings creative thinking to science

    The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

    By Alexandra Pecci • June 27, 2022
  • Image attribution tooltip
    Stock via Getty Images

    4 tips for landing your next C-suite role in pharma

    Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

    By June 23, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Kronos Bio's Barbara Kosacz

    Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

    By June 21, 2022
  • Image attribution tooltip
    Michael Gibney/PharmaVoice

    #DIA2022: How the industry's top regulator views the future of healthcare

    In the evolution of healthcare, data is the linchpin to making drug development more efficient.

    By June 21, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech spotlight: Karuna Therapeutics' mission to rejuvenate the field of neuroscience

    An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.

    By Kim Ribbink • June 16, 2022
  • Image attribution tooltip
    ChiccoDodiFC via Getty Images

    A patient-funded ALS drug offers hope where few treatments exist

    Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

    By Kelly Bilodeau • June 15, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Tango Therapeutics' Dr. Barbara Weber

    A pioneer in genetic medicine, Dr. Barbara Weber continues to push the envelope to expand the reach of therapies based on genetic targeting.

    By June 14, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Why biomanufacturing is the next innovation frontier for genomic therapies

    While cell and gene therapy research has accelerated quickly, manufacturing in the space hasn’t quite kept up, Danaher’s Chief Science Officer JC Gutiérrez-Ramos says.

    By June 13, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Making moves: Civica, Astellas, Inozyme and more announce key new hires

    The latest hiring moves from Civica, Astella, Inozyme and the Flagship Pioneering-founded Tessera Therapeutics. 

    By June 13, 2022
  • Image attribution tooltip
    Permission granted by Editas/Gilmore O'Neill
    Q&A

    First 90 Days: Editas Medicine's Gilmore O'Neill

    The first-time CEO is flexing new muscles as he steers the gene editing company through clinical trials and beyond.

    By June 13, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    A combo of precision meds and diagnostics could disrupt mental healthcare

    HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.

    By Kelly Bilodeau • June 8, 2022
  • Image attribution tooltip

    Permission granted by David Jimenez.

    Q&A

    First 90 Days: Janssen Immunology's David Jimenez

    The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.

    By June 6, 2022
  • Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    By Alexandra Pecci • June 1, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Cell and gene therapy advances coming fast and furious

    A peek into R&D at the Mass General Brigham network reveals up-and-coming treatments pushing the boundaries of what’s possible in medicine.

    By Kelly Bilodeau • June 1, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: OcuTerra Therapeutics' Kerrie Brady

    The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.

    By June 1, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Making moves: Inovio, Veru, MindMed and more announce key new hires

    The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio. 

    By May 25, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    The UK-based company that's striving to overcome the limitations of T cell receptor innovation

    Etcembly’s CEO, Michelle Teng, shares why a platform approach to T cell receptors can advance and democratize innovation.

    By Kim Ribbink • May 23, 2022
  • Image attribution tooltip

    Permission granted by Michelle Keefe. 

    Q&A

    First 90 Days: Syneos Health's Michelle Keefe

    The newly minted CEO is leaning on her 30 years of experience leading high-performance teams to make her mark at Syneos.

    By May 23, 2022
  • Image attribution tooltip
    Permission granted by Vidya Viswanathan

    Tracking trends in healthcare, from tech to patient care

    High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.

    By May 20, 2022